Skip to main content
MYUNGMOON PHARM CO.,LTD logo

MYUNGMOON PHARM CO.,LTD — Investor Relations & Filings

Ticker · 017180 ISIN · KR7017180001 KO Manufacturing
Filings indexed 250 across all filing types
Latest filing 2022-11-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 017180

About MYUNGMOON PHARM CO.,LTD

http://mmpharm.co.kr/en/main/

Myungmoon Pharm Co., Ltd. is a research-based pharmaceutical company engaged in the development, manufacturing, and commercialization of healthcare products. The company produces over 250 specialized and general medicines, holding more than 400 manufacturing licenses. Its portfolio includes both ethical (ETC) and over-the-counter (OTC) drugs, with key product areas in anesthetics, digestive agents, and antitussives. The company's operations encompass the wholesale, import, and export of its pharmaceutical products for domestic and international markets.

Recent filings

Filing Released Lang Actions
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Myungmoon Pharm Co., Ltd., covering the period from January 1, 2022, to September 30, 2022. It contains detailed financial data, business operations, management information, and capital structure, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-11-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% report). It details the shareholding status, changes in share ownership, and collateral agreements (stock-backed loans) of a major shareholder (Woo Seok-min) in Myungmoon Pharm. This type of filing is specifically categorized as a Major Shareholding Notification (MRQ) in the provided schema.
2022-11-10 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the shareholding status, changes in shareholding, and collateral agreements (stock-backed loans) of a major shareholder (Woo Seok-min) in Myungmoon Pharm Co., Ltd. This falls under the category of Major Shareholding Notification.
2022-10-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in shareholding, and specifically mentions changes in stock collateral loan agreements (주식담보대출 계약 내용의 변경). This type of filing is used to notify the market of significant ownership changes or changes in the nature of holdings by major shareholders, which falls under the 'Major Shareholding Notification' category.
2022-09-23 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document details the shareholding status, changes in ownership, and collateral agreements of a major shareholder (Woo Seok-min) in Myungmoon Pharm Co., Ltd. It falls under the category of 'Major Shareholding Notification' as it reports significant ownership levels and changes therein.
2022-08-16 Korean
반기보고서 (2022.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for Myungmoon Pharm Co., Ltd., covering the period from January 1, 2022, to June 30, 2022. It contains detailed financial information, business descriptions, and management disclosures, which are characteristic of an interim financial report. It is not an announcement of a report (RPA) or a certification, as it contains substantive financial data and tables. H1 2022
2022-08-16 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.